Nissay Asset Management’s AbbVie ABBV Stock Holding History

Nissay Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$41.5M	Sell	223,397 -286	-0.1%	-$53.1K	0.24%	68
2025 Q1	$46.9M	Buy	223,683 +1,943	+0.9%	+$407K	0.3%	58
2024 Q4	$39.5M	Buy	221,740 +2,103	+1%	+$374K	0.24%	64
2024 Q3	$43.4M	Buy	219,637 +2,636	+1%	+$521K	0.27%	58
2024 Q2	$37.2M	Buy	217,001 +5,767	+3%	+$989K	0.25%	63
2024 Q1	$38.5M	Buy	211,234 +183	+0.1%	+$33.3K	0.27%	57
2023 Q4	$32.7M	Sell	211,051 -557	-0.3%	-$86.3K	0.26%	60
2023 Q3	$31.5M	Buy	211,608 +2,031	+1%	+$303K	0.28%	56
2023 Q2	$28.2M	Sell	209,577 -9,305	-4%	-$1.25M	0.24%	60
2023 Q1	$34.9M	Sell	218,882 -7,571	-3%	-$1.21M	0.31%	58
2022 Q4	$36.6M	Sell	226,453 -6,215	-3%	-$1M	0.35%	55
2022 Q3	$31.2M	Buy	232,668 +7,337	+3%	+$985K	0.33%	54
2022 Q2	$34.5M	Buy	225,331 +9,492	+4%	+$1.45M	0.34%	47
2022 Q1	$35M	Buy	215,839 +3,708	+2%	+$601K	0.3%	55
2021 Q4	$28.7M	Buy	212,131 +5,143	+2%	+$696K	0.22%	71
2021 Q3	$22.3M	Buy	206,988 +11,593	+6%	+$1.25M	0.19%	80
2021 Q2	$22M	Sell	195,395 -26,188	-12%	-$2.95M	0.19%	83
2021 Q1	$24M	Sell	221,583 -4,325	-2%	-$468K	0.24%	74
2020 Q4	$24.2M	Buy	225,908 +29,528	+15%	+$3.16M	0.36%	66
2020 Q3	$17.2M	Sell	196,380 -21,298	-10%	-$1.87M	0.29%	78
2020 Q2	$21.4M	Buy	217,678 +48,568	+29%	+$4.77M	0.41%	65
2020 Q1	$12.9M	Buy	169,110 +6,993	+4%	+$533K	0.33%	82
2019 Q4	$14.4M	Sell	162,117 -1,131	-0.7%	-$100K	0.32%	84
2019 Q3	$12.4M	Buy	163,248 +4,159	+3%	+$315K	0.3%	81
2019 Q2	$11.6M	Sell	159,089 -1,190	-0.7%	-$86.5K	0.29%	86
2019 Q1	$12.9M	Sell	160,279 -7,365	-4%	-$594K	0.34%	72
2018 Q4	$15.5M	Sell	167,644 -6,336	-4%	-$584K	0.47%	46
2018 Q3	$16.5M	Sell	173,980 -6,075	-3%	-$575K	0.44%	52
2018 Q2	$16.7M	Buy	180,055 +1,357	+0.8%	+$126K	0.49%	45
2018 Q1	$16.9M	Sell	178,698 -21,408	-11%	-$2.03M	0.53%	44
2017 Q4	$19.4M	Buy	+200,106	New	+$19.4M	0.59%	41